首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌肺转移机制及治疗进展
引用本文:孙元元,张苧之,曹孟儒. 乳腺癌肺转移机制及治疗进展[J]. 实用肿瘤学杂志, 2022, 36(2): 173-177. DOI: 10.11904/j.issn.1002-3070.2022.02.013
作者姓名:孙元元  张苧之  曹孟儒
作者单位:哈尔滨医科大学附属肿瘤医院乳腺内四科(哈尔滨 150081)
基金项目:1.2020黑龙江省博士后科研启动金(编号:LBH-Q20040);2.黑龙江省人社厅2017留学人员科技项目择优资助
摘    要:肺部是晚期乳腺癌的常见转移部位,肺转移可能引起咳嗽、咯血、疼痛、胸腔积液和肺功能障碍等临床症状,严重影响患者的生活质量。目前关于乳腺癌肺转移治疗有局部治疗和全身治疗,但是存在肺转移的乳腺癌患者的生存率仍然很低,提高患者的疗效和延长生存时间一直是患者及医务工作者关心的热点问题。本文将对乳腺癌肺转移机制及肺转移最新治疗进展进行综述,以期为乳腺癌肺转移患者临床治疗提供新思路。

关 键 词:乳腺癌  肺转移  全身治疗  局部治疗  转移性乳腺癌  
收稿时间:2021-03-22

The mechanism and treatment progress of breast cancer lung metastasis
SUN Yuanyuan,ZHANG Ningzhi,CAO Mengru. The mechanism and treatment progress of breast cancer lung metastasis[J]. Journal of Practical Oncology, 2022, 36(2): 173-177. DOI: 10.11904/j.issn.1002-3070.2022.02.013
Authors:SUN Yuanyuan  ZHANG Ningzhi  CAO Mengru
Affiliation:Department of Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,China
Abstract:Lung is a common metastatic site of advanced breast cancer.Lung metastasis may cause cough,hemoptysis,pain,pleural effusion and pulmonary dysfunction and other clinical symptoms,which seriously affect the life quality of patients.At present,there are local and systemic treatments for breast cancer lung metastasis,but the survival rate of breast cancer patients with lung metastasis is still very low.Improving the efficacy of patients and prolonging the survival time have been hot issues of concern to patients and medical workers.This paper briefly reviews the mechanism of breast cancer lung metastasis and the latest treatment progress of lung metastasis,in order to provide new ideas for the clinical treatment of breast cancer patients with lung metastasis.
Keywords:Breast cancer  Lung metastasis  Systemic therapy  Local therapy  Metastatic breast cancer  
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号